Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the ...

A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric ...

Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell ...

Psychiatric genetics offers insights into the complex, heritable nature of mental illnesses such as schizophrenia and bipolar ...

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal ...

BioArctic AB Class B ( ($SE:BIOA.B) ) just unveiled an announcement. Eisai, in partnership with BioArctic AB, has completed the rolling submission ...

All In Solutions California, a premier addiction treatment center serving the region, has expanded its specialized treatment ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Scientists from Tulane University and The University of Texas at Dallas have discovered a new way that nerve cells communicate – by releasing an enzyme outside the cell that switches on pain signaling ...

The release of CMS’s new Innovation Center Strategy isn’t just a change in policy; it’s a realignment of the patient journey. As value-based care gains new momentum, we are being asked to look at care ...

The Food and Drug Administration (FDA) has issued a statement, published electronically in the New England Journal of ...